Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

DPCP works best for alopecia areata, but more research is needed for better treatments.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

DPC-Exos can help regenerate hair follicles and heal wounds by activating the Wnt/β-catenin pathway.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Peficitinib can turn human fibroblasts into cells that help grow hair.

A man developed severe skin reactions after using a treatment for hair loss.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

A child with skin and heart issues had rare genetic mutations affecting skin and heart cell cohesion.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

PDCD4 is important for controlling skin cell growth and healing.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.